{
  "drug_name": "Carfilzomib",
  "aliases": ["Kyprolis"],
  "indications": ["Multiple Myeloma"],
  "targets": [
    {"protein": "PSMB5", "interaction_type": "inhibits"},
    {"protein": "PSMB8", "interaction_type": "inhibits"},
    {"protein": "PSMB9", "interaction_type": "inhibits"}
  ],
  "interacts_with": [
    {"drug": "Dexamethasone", "effect": "increased thromboembolism risk", "evidence": "FDA label"},
    {"drug": "Cyclophosphamide", "effect": "bone marrow suppression", "evidence": "clinical study"}
  ],
  "adverse_effects": [
    {"name": "Peripheral Neuropathy", "source": "SIDER"},
    {"name": "Cardiac Toxicity", "source": "FDA label"},
    {"name": "Renal Dysfunction", "source": "clinical study"}
  ],
  "mechanism_summary": "Inhibits the proteolytic activity of the 20S proteasome"
}